CDKN1C anticorps (N-Term) (Cy3)
Aperçu rapide pour CDKN1C anticorps (N-Term) (Cy3) (ABIN7982507)
Antigène
Voir toutes CDKN1C AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Fonction
- Anti-p57 Kip2/CDKN1C Antibody Cy3 Conjugated
-
Réactivité croisée (Details)
- No cross-reactivity with other proteins.
-
Homologie
- identical to the related mouse sequence.
-
Purification
- Immunogen affinity purified.
-
Immunogène
- A synthetic peptide corresponding to a sequence at the N-terminus of human p57 Kip2/CDKN1C, identical to the related mouse sequence.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Flow Cytometry, 1-3 μg/1x106 cells
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Date de péremption
- 12 months
-
-
- CDKN1C (Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))
-
Autre désignation
- CDKN1C
-
Sujet
-
Background: Cyclin-dependent kinase inhibitor 1C (p57, Kip2), also known as CDKN1C, is a protein which in humans is encoded by the CDKN1C imprinted gene. It is mapped to 11p15.4. This gene is imprinted, with preferential expression of the maternal allele. The encoded protein is a tight-binding, strong inhibitor of several G1 cyclin/Cdk complexes and a negative regulator of cell proliferation. Mutations in this gene are implicated in sporadic cancers and Beckwith-Wiedemann syndorome, suggesting that this gene is a tumor suppressor candidate. Three transcript variants encoding two different isoforms have been found for this gene.
Gene Full Name: cyclin dependent kinase inhibitor 1C
-
ID gène
- 1028
-
UniProt
- P49918
-
Pathways
- Cycle Cellulaire, Dopaminergic Neurogenesis
Antigène
-